GSK and Theravance reveal positive results from three Phase III trials in COPD

GlaxoSmithKline (GSK) and Theravance have reported positive results from three Phase III trials comparing Anoro Ellipta with Seretide Diskus and Advair Diskus in patients with chronic obstructive pulmonary disease (COPD).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news